The information below represents material from the conference and includes data from the 503B Market Landscape Study conducted by the FDA in 2022. These points include emerging compounding trends and key industry insights shared by FDA.
Read More
Business Consulting
Cleanroom Design & Buildout
Fractional Leadership
Product Development
Environmental Monitoring Program Design
Operations
Personnel Training
Protocol Design
SOP Customization
Accreditation
Adverse Drug Event Reporting
Gap Analysis
Expert Witness
Licensing & Registration
Probation Monitoring
Recalls
Regulatory Response
Quality System Overhaul
Supplier Audit